Nehal Mehta of the Perelman School of Medicine comments on a cholesterol drugs study.
Perelman School of Medicine
John Detre of the Perelman School of Medicine comments on a new way to diagnose Alzheimer’s disease.
Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School comments on President Obama’s stance on health care for Americans.
Brian Litt of the Perelman School of Medicine discusses research he led about developing a microelectronic device to help map brain activity.
PHILADELPHIA - By studying tumor biology at the molecular level, researchers are gaining a deeper understanding of drug resistance - and how to avoid it by designing pediatric cancer treatments tailored to specific mutations in a child’s DNA. In a fruitful collaboration, pediatric oncologists and biochemists are targeting neuroblastoma, an often-deadly childhood cancer of the peripheral nervous system.